Literature DB >> 1761524

Production and characterization of functional domains of human fibronectin expressed in Escherichia coli.

F Kimizuka1, Y Taguchi, Y Ohdate, Y Kawase, T Shimojo, K Hashino, I Kato, K Sekiguchi, K Titani.   

Abstract

An efficient expression system was constructed in Escherichia coli that produced a 33-kDa fragment, C-274, of human fibronectin with a strong cell-adhesive activity. The entire sequence of the heparin-binding domain with 271 amino acids, H-271, was also expressed. Deletion analysis of the type III repeats showed that the heparin-binding site was at type III-13. The cell-adhesive activity of a fusion protein, CH-271, containing the cell- and the heparin-binding domains was twice that of C-274 when BHK but not B16-F10 melanoma cells were tested; H-271 alone was inactive. Recombinant proteins containing the CS1 sequence of the IIICS region were more active than C-274 and CH-271 with B16-F10. However, H-296, which contained both H-271 and CS1, was almost inactive with BHK. CH-296, which contained CS1 at the C-terminus of CH-271, was more active with B16-F10 than H-296 and C-CS1, which was produced by the deletion of H-271 from CH-296. Thus, the cell-binding domain was active with both kinds of cells. The heparin-binding domain promoted the adhesion of both kinds of cells only when linked to the cell-binding domain or CS1. CS1 was specific for the adhesion of B16-F10 but was not essential.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1761524     DOI: 10.1093/oxfordjournals.jbchem.a123572

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  13 in total

1.  Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors.

Authors:  B Blom; M H Heemskerk; M C Verschuren; J J van Dongen; A P Stegmann; A Q Bakker; F Couwenberg; P C Res; H Spits
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

2.  Construction of expressing plasmids of recombinant FN polypeptides with bifunctional-domain and the characterization of the products expressed in E. coli.

Authors:  Z Feng; G Zhang; D Li; H Zhang
Journal:  J Tongji Med Univ       Date:  1996

3.  Comparative study on the inhibitory effect of recombinant FN polypeptide CH50 and CH56 on the metastasis of melanoma cells.

Authors:  G Zhang; Z Feng; H Zhang; D Li; Q Fan
Journal:  J Tongji Med Univ       Date:  1997

4.  Effect of fragment Asp1961-Glu1978 in fibronectin on the expression of triple-domain polypeptide in E. coli.

Authors:  D Li; Z Feng; G Zhang; H Zhang; Q Fan
Journal:  J Tongji Med Univ       Date:  1998

5.  High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.

Authors:  K E Pollok; H Hanenberg; T W Noblitt; W L Schroeder; I Kato; D Emanuel; D A Williams
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells.

Authors:  D A Wilcox; J C Olsen; L Ishizawa; M Griffith; G C White
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

7.  Heparin inhibits retrovirus binding to fibronectin as well as retrovirus gene transfer on fibronectin fragments.

Authors:  D Carstanjen; P Dutt; T Moritz
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism.

Authors:  Errol S Wijelath; Salman Rahman; Mayumi Namekata; Jacqueline Murray; Tomoaki Nishimura; Zohreh Mostafavi-Pour; Yatin Patel; Yasuo Suda; Martin J Humphries; Michael Sobel
Journal:  Circ Res       Date:  2006-09-28       Impact factor: 17.367

9.  VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.

Authors:  J C van der Loo; X Xiao; D McMillin; K Hashino; I Kato; D A Williams
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

10.  Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells.

Authors:  Shicheng Yang; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunother       Date:  2008 Nov-Dec       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.